These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38292193)

  • 1. Transcriptomic analysis identifies the neuropeptide cortistatin (CORT) as an inhibitor of temozolomide (TMZ) resistance by suppressing the NF-κB-MGMT signaling axis in human glioma.
    He Z; Peng B; Wang Q; Tian J; Liu P; Feng J; Liao Y; Chen L; Jia P; Tang J
    Genes Dis; 2024 May; 11(3):100977. PubMed ID: 38292193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of temozolomide resistance in glioma cells via the RIP2/NF-κB/MGMT pathway.
    Hu YH; Jiao BH; Wang CY; Wu JL
    CNS Neurosci Ther; 2021 May; 27(5):552-563. PubMed ID: 33460245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of NF-κB results in anti-glioma activity and reduces temozolomide-induced chemoresistance by down-regulating MGMT gene expression.
    Yu Z; Chen Y; Wang S; Li P; Zhou G; Yuan Y
    Cancer Lett; 2018 Aug; 428():77-89. PubMed ID: 29705182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BKM120 sensitizes C6 glioma cells to temozolomide via suppression of the PI3K/Akt/NF-κB/MGMT signaling pathway.
    Li M; Liang RF; Wang X; Mao Q; Liu YH
    Oncol Lett; 2017 Dec; 14(6):6597-6603. PubMed ID: 29151909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnolol and Temozolomide exhibit a synergistic anti-glioma activity through MGMT inhibition.
    Kundu M; Das S; Nandi S; Dhara D; Mandal M
    Biochim Biophys Acta Mol Basis Dis; 2023 Oct; 1869(7):166782. PubMed ID: 37286145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NF-κB inhibitor reverses temozolomide resistance in human glioma TR/U251 cells.
    Wang X; Jia L; Jin X; Liu Q; Cao W; Gao X; Yang M; Sun B
    Oncol Lett; 2015 Jun; 9(6):2586-2590. PubMed ID: 26137111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disruption of NF-κB signaling by fluoxetine attenuates MGMT expression in glioma cells.
    Song T; Li H; Tian Z; Xu C; Liu J; Guo Y
    Onco Targets Ther; 2015; 8():2199-208. PubMed ID: 26346978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced MGMT expression contributes to temozolomide resistance in glioma stem-like cells.
    Qiu ZK; Shen D; Chen YS; Yang QY; Guo CC; Feng BH; Chen ZP
    Chin J Cancer; 2014 Feb; 33(2):115-22. PubMed ID: 23958055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tubeimoside-I sensitizes temozolomide-resistant glioblastoma cells to chemotherapy by reducing MGMT expression and suppressing EGFR induced PI3K/Akt/mTOR/NF-κB-mediated signaling pathway.
    Tang Q; Cao H; Tong N; Liu Y; Wang W; Zou Y; Xu L; Zeng Z; Xu W; Yin Z; Ma W; Wang Q
    Phytomedicine; 2022 May; 99():154016. PubMed ID: 35278900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. β-catenin contributes to cordycepin-induced MGMT inhibition and reduction of temozolomide resistance in glioma cells by increasing intracellular reactive oxygen species.
    Bi Y; Li H; Yi D; Bai Y; Zhong S; Liu Q; Chen Y; Zhao G
    Cancer Lett; 2018 Oct; 435():66-79. PubMed ID: 30081068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Curcumol reverses temozolomide resistance in glioma cells by regulating the UTX/MGMT axis].
    Sun J; Xing J; Tan R; Qian Y; Tian N
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 Oct; 43(10):1697-1705. PubMed ID: 37933645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms for hypoxia
    Zhao H; Meng L; Liao X; Liu Y; Mo X; Gong M; Liao Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Jul; 47(7):829-838. PubMed ID: 36039578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA UCA1/miR-182-5p/MGMT axis modulates glioma cell sensitivity to temozolomide through MGMT-related DNA damage pathways.
    Cheng M; Wang Q; Chen L; Zhao D; Tang J; Xu J; He Z
    Hum Pathol; 2022 May; 123():59-73. PubMed ID: 35219686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quercetin induces MGMT
    Wang W; Yuan X; Mu J; Zou Y; Xu L; Chen J; Zhu X; Li B; Zeng Z; Wu X; Yin Z; Wang Q
    Phytomedicine; 2023 Sep; 118():154933. PubMed ID: 37451151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mannose inhibits proliferation and promotes apoptosis to enhance sensitivity of glioma cells to temozolomide through Wnt/β-catenin signaling pathway.
    Fei YQ; Shi RT; Zhou YF; Wu JZ; Song Z
    Neurochem Int; 2022 Jul; 157():105348. PubMed ID: 35490896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiated embryonic chondrocyte-expressed gene 1 promotes temozolomide resistance by modulating the SP1-MGMT axis in glioblastoma.
    Lv W; Li Q; Jia B; He Y; Ru Y; Guo Q; Li X; Lin W
    Am J Transl Res; 2021; 13(4):2331-2349. PubMed ID: 34017393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemoresistance to temozolomide in human glioma cell line U251 is associated with increased activity of O6-methylguanine-DNA methyltransferase and can be overcome by metronomic temozolomide regimen.
    Pan Q; Yang XJ; Wang HM; Dong XT; Wang W; Li Y; Li JM
    Cell Biochem Biophys; 2012 Jan; 62(1):185-91. PubMed ID: 21892781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. H19 induced by oxidative stress confers temozolomide resistance in human glioma cells via activating NF-κB signaling.
    Duan S; Li M; Wang Z; Wang L; Liu Y
    Onco Targets Ther; 2018; 11():6395-6404. PubMed ID: 30323617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of levetiracetam and IFN-α increased temozolomide efficacy in MGMT-positive glioma.
    Ni XR; Guo CC; Yu YJ; Yu ZH; Cai HP; Wu WC; Ma JX; Chen FR; Wang J; Chen ZP
    Cancer Chemother Pharmacol; 2020 Dec; 86(6):773-782. PubMed ID: 33074386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AP-2α decreases TMZ resistance of recurrent GBM by downregulating MGMT expression and improving DNA damage.
    Huang G; Ouyang M; Xiao K; Zhou H; Zhong Z; Long S; Li Z; Zhang Y; Li L; Xiang S; Ding X
    Life Sci; 2024 Nov; 357():123111. PubMed ID: 39369843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.